Perspective - (2025) Volume 9, Issue 6
Received: 01-Dec-2025, Manuscript No. jmp-26-190070;
Editor assigned: 03-Dec-2025, Pre QC No. P-190070;
Reviewed: 17-Dec-2025, QC No. Q-190070;
Revised: 22-Dec-2025, Manuscript No. R-190070;
Published:
29-Dec-2025
, DOI: 10.37421/2684-4931.2025.9.284
Citation: Rossi, Valentina. ”Bacterial Persistence: Dormancy, Survival, and Chronic Infections.” J Microb Path 09 (2025):284.
Copyright: © 2025 Rossi V. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Persistent bacterial populations represent a critical challenge in infectious disease treatment, characterized by their ability to enter dormant states to survive adverse conditions, including antibiotic exposure, thereby leading to treatment failure and disease relapse. This dormancy is a sophisticated adaptive response involving extensive metabolic rewiring, significant alterations in gene expression patterns, and modifications in cellular structure. Understanding the fundamental molecular basis governing this survival strategy is paramount for the development of innovative therapeutic approaches capable of effectively targeting these remarkably resilient bacterial populations. Key cellular pathways implicated in this phenomenon include the stringent response, the activation of persistence regulons, and the accumulation of specific small nucleoid-associated proteins that play a crucial role in safeguarding the bacterial DNA from various forms of damage. Equally vital to the study of persistence is the bacterium's capacity to reactivate from this dormant state, a process whose triggers are still under active investigation, often involving complex environmental signals or cues originating from the host organism. The emergence of bacterial persister cells, a distinct subpopulation within a bacterial culture exhibiting a pronounced tolerance to antibiotics, poses a significant impediment to the successful treatment of infectious diseases. These persister cells are distinguished by their lack of genetic resistance; instead, they enter a reversible dormant state that renders them phenotypically tolerant. The molecular mechanisms that drive the formation and maintenance of persistence are multifaceted, with notable examples including the intracellular accumulation of cyclic di-guanosine monophosphate (c-di-GMP), a second messenger that promotes biofilm formation and concomitantly reduces the bacterial growth rate, and the intricate involvement of toxin-antitoxin (TA) systems, which can effectively lead to a marked reduction in cellular metabolic activity. A comprehensive understanding of the triggers that initiate this state and the complex regulatory networks that govern it is fundamental to identifying effective strategies for the elimination of these troublesome persister cells. Dormancy within bacterial populations serves as a critical determinant in the recalcitrance of many infections, extending beyond mere antibiotic tolerance. Dormant cells demonstrate a remarkable resistance not only to antimicrobial agents but also to the host's immune responses and are exceptionally adept at surviving in environments characterized by nutrient scarcity. The stringent response, a pivotal cellular mechanism orchestrated by the proteins RelA and SpoT, plays a central role in establishing and maintaining this dormant state by globally downregulating macromolecular synthesis and promoting the conservation of cellular energy. Extensive research has successfully identified specific stress response pathways and regulatory small RNAs that actively contribute to both the establishment and the sustained maintenance of bacterial dormancy, thereby highlighting potential avenues for novel therapeutic interventions. The inherent ability of bacteria to form biofilms is intrinsically and intricately linked to the phenomenon of bacterial persistence. Within the complex architecture of biofilms, distinct subpopulations of dormant cells frequently emerge, significantly contributing to the pathogenesis of chronic infections. The extracellular matrix of the biofilm not only provides a physical barrier that shields the bacterial cells but also fosters metabolic heterogeneity within the biofilm community, which in turn promotes a general tolerance to various antimicrobial agents. Ongoing research efforts are actively focused on uncovering the specific signaling molecules and transcriptional regulators that govern the critical transition into and the subsequent maintenance of this dormant, persistent state within the highly complex and dynamic biofilm microenvironment. Toxin-antitoxin (TA) systems are recognized as crucial regulators orchestrating bacterial dormancy and persistence. These genetic elements, which consist of a stable toxin protein and its cognate antitoxin that neutralizes its activity, can induce a state of bacteriostasis or even cell death upon the depletion of the antitoxin. This mechanism is effectively exploited by persister cells to arrest their growth and consequently develop resistance to antibiotic treatments. Recent scientific advancements have significantly elucidated the extensive diversity of TA systems and have begun to unravel their specific roles in both initiating and sustaining the dormant physiological state within bacterial populations, thereby presenting promising targets for therapeutic strategies aimed at disrupting bacterial persistence. The transition into and out of a dormant state in bacterial populations is a highly dynamic process that is meticulously regulated by intricate intracellular signaling networks. Within persistent bacterial populations, individual cells possess the capacity to enter a reversible dormant state, a condition characterized by significantly reduced metabolic activity and a concurrently increased tolerance to various stressors. Several factors, including the availability of nutrients, the presence of specific stress signals within the environment, and the intracellular accumulation of particular signaling molecules such as ppGpp (guanosine tetraphosphate), have been implicated in the maintenance of this dormant physiological state. A comprehensive understanding of the molecular switches that govern this reversible dormancy is therefore considered paramount for the successful development of strategies to overcome persistent bacterial infections. Bacterial persistence extends beyond a mere phenomenon of antibiotic tolerance; it represents a fundamental survival strategy enabling bacteria to endure a wide array of environmental stresses, including the host's innate immune responses. Dormant bacterial cells frequently exhibit significant alterations in their cell wall composition, leading to a reduced susceptibility to complement-mediated lysis, and a diminished inflammatory response from the host. Elucidating the sophisticated immune evasion mechanisms that are employed by these dormant bacteria is absolutely critical for the effective management of chronic and relapsing infections. Small proteins, a class of proteins that includes those not traditionally translated from annotated open reading frames, are increasingly recognized as pivotal players in the complex processes of bacterial dormancy. These diminutive proteins can perform diverse functions, acting as molecular chaperones to maintain protein integrity, as modulators of stress responses to protect the cell, or as regulators of key metabolic pathways, all of which contribute to the overall protective dormant state of persister cells. Their capacity for rapid synthesis and their wide-ranging functional roles underscore a previously underappreciated layer of regulatory control in bacterial adaptation to stress and the successful maintenance of dormancy. The energy metabolism of dormant bacterial persister cells undergoes a profound alteration, primarily characterized by a state of significantly reduced metabolic activity. This lowered energy demand is a crucial adaptation that allows these cells to survive periods of nutrient scarcity and significantly contributes to their observed tolerance to antibiotics. A detailed understanding of the specific metabolic pathways that are either upregulated or downregulated in dormant cells, such as those involved in cellular respiration or fermentation, is therefore essential for the rational design of strategies aimed at reawakening these dormant cells or specifically targeting their unique metabolic vulnerabilities. The capacity of bacteria to successfully recover from a dormant state and transition back into an active growth phase is a critically important aspect of the persistence of bacterial infections within a host. This reactivation process is frequently initiated by specific environmental cues, such as the replenishment of essential nutrients or significant changes in ambient temperature. The molecular mechanisms that govern this transition back to active growth involve the rapid deactivation of previously engaged stress response pathways and the prompt restoration of normal cellular metabolic processes. Identifying these precise reactivation triggers and the associated complex regulatory cascades could offer novel and valuable therapeutic targets for the prevention of disease relapse caused by persistent bacterial infections.
Persistent bacterial populations represent a significant challenge in the treatment of infectious diseases, as they are capable of entering a dormant state that confers resistance to antibiotics, ultimately leading to treatment failures and recurrent infections. This dormancy is a complex adaptive mechanism involving substantial metabolic rewiring, altered gene expression, and changes in cellular structure, making it crucial to understand its molecular underpinnings for developing effective therapies. Key processes involved include the stringent response, persistence regulons, and the accumulation of small proteins that protect DNA. The ability of these bacteria to reactivate from dormancy, often triggered by environmental signals, is also a critical area of study. Persister cells, a subpopulation with high antibiotic tolerance, are a major hurdle in combating bacterial infections. Unlike resistant cells, persisters are not genetically mutated but enter a reversible dormant state. Molecular drivers of persistence include elevated levels of cyclic di-guanosine monophosphate (c-di-GMP), which promotes biofilm formation and slows growth, and the action of toxin-antitoxin systems that reduce metabolic activity. Understanding these regulatory mechanisms is vital for developing strategies to eliminate persister cells. Dormancy in bacteria is a critical factor in the recalcitrance of infections, extending beyond antibiotic tolerance to include resistance to host immune responses and survival in nutrient-poor environments. The stringent response, mediated by RelA and SpoT proteins, is central to dormancy by globally downregulating macromolecular synthesis and conserving energy. Research has identified specific stress response pathways and regulatory RNAs that contribute to the establishment and maintenance of dormancy, presenting potential therapeutic targets. The formation of bacterial biofilms is intimately linked to the development of persistence. Within biofilms, dormant subpopulations emerge, contributing to chronic infections. The biofilm matrix offers physical protection, while metabolic heterogeneity within the biofilm enhances tolerance to antimicrobials. Current research aims to identify the signaling molecules and transcriptional regulators controlling the transition to and maintenance of this dormant, persistent state in the complex biofilm microenvironment. Toxin-antitoxin (TA) systems are key regulators of bacterial dormancy and persistence. These systems, comprising a toxic protein and its antitoxin, can induce bacteriostasis or cell death upon antitoxin depletion, a mechanism used by persisters to arrest growth and resist antibiotics. Recent studies have highlighted the diversity of TA systems and their specific roles in initiating and maintaining dormancy, offering potential targets for disrupting this survival strategy. The transition into and out of bacterial dormancy is a dynamic process governed by complex signaling networks. Persistent bacteria can enter a reversible dormant state characterized by low metabolic activity and increased tolerance. Factors such as nutrient availability, stress signals, and the accumulation of molecules like ppGpp are implicated in maintaining this state. Understanding these molecular switches is crucial for overcoming persistent infections. Bacterial persistence is not merely about antibiotic tolerance but also a survival strategy against various environmental stresses, including host immune responses. Dormant cells often display altered cell wall composition, reduced susceptibility to complement lysis, and a diminished inflammatory response from the host. Elucidating these immune evasion mechanisms is vital for managing chronic and relapsing infections. Small proteins, including those not translated from annotated open reading frames, are emerging as important factors in bacterial dormancy. These proteins can function as chaperones, stress modulators, or metabolic regulators, contributing to the protective state of persister cells. Their rapid synthesis and diverse functions reveal a novel regulatory layer in bacterial adaptation to stress and dormancy maintenance. The energy metabolism of dormant persister cells is significantly altered, characterized by low metabolic activity. This reduced energy demand enables survival during nutrient scarcity and contributes to antibiotic tolerance. Understanding the specific metabolic pathways that are upregulated or downregulated in dormant cells, such as those involved in respiration or fermentation, is essential for developing strategies to reawaken these cells or target their metabolic vulnerabilities. The ability of bacteria to recover from dormancy and resume active growth is a critical aspect of infection persistence. Reactivation is often triggered by environmental cues like nutrient replenishment or temperature changes. Molecular mechanisms include rapid deactivation of stress response pathways and restoration of metabolic processes. Identifying these reactivation triggers and regulatory cascades could provide new targets for preventing disease relapse.
Bacterial persistence is a complex survival strategy where populations enter a dormant state to withstand antibiotics and environmental stresses, leading to treatment failure and chronic infections. This dormancy involves metabolic rewiring, altered gene expression, and changes in cellular structure, with key roles played by the stringent response, persistence regulons, toxin-antitoxin systems, and small proteins. Persister cells, characterized by high antibiotic tolerance, exhibit reduced metabolic activity and can form within biofilms. Their ability to reactivate from dormancy is triggered by environmental cues and is crucial for infection persistence. Understanding these mechanisms, including metabolic adaptations and immune evasion strategies, is essential for developing new therapies to combat persistent bacterial infections.
None
None
Journal of Microbial Pathogenesis received 17 citations as per Google Scholar report
